Production (Stage)
Utah Medical Products, Inc.
UTMD
$53.76
$0.100.19%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -19.92% | -18.56% | -14.35% | -10.28% | -6.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -19.92% | -18.56% | -14.35% | -10.28% | -6.54% |
| Cost of Revenue | -18.55% | -16.97% | -10.09% | -3.62% | 0.56% |
| Gross Profit | -20.88% | -19.62% | -17.11% | -14.39% | -10.91% |
| SG&A Expenses | -23.92% | -31.17% | -28.19% | -18.55% | -8.92% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -19.83% | -20.81% | -15.31% | -7.92% | -2.23% |
| Operating Income | -20.08% | -14.68% | -12.80% | -13.92% | -13.03% |
| Income Before Tax | -19.76% | -16.36% | -11.90% | -11.38% | -6.97% |
| Income Tax Expenses | -14.39% | -15.23% | -21.60% | -20.02% | -17.21% |
| Earnings from Continuing Operations | -20.87% | -16.60% | -9.74% | -9.39% | -4.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.87% | -16.60% | -9.74% | -9.39% | -4.52% |
| EBIT | -20.08% | -14.68% | -12.80% | -13.92% | -13.03% |
| EBITDA | -25.82% | -25.15% | -24.17% | -20.72% | -16.04% |
| EPS Basic | -16.34% | -13.77% | -8.18% | -8.79% | -4.37% |
| Normalized Basic EPS | -14.71% | -10.01% | -5.89% | -5.62% | -3.05% |
| EPS Diluted | -16.23% | -13.62% | -8.00% | -8.64% | -4.48% |
| Normalized Diluted EPS | -14.60% | -9.84% | -5.72% | -5.51% | -3.03% |
| Average Basic Shares Outstanding | -5.51% | -3.46% | -1.79% | -0.72% | -0.16% |
| Average Diluted Shares Outstanding | -5.64% | -3.64% | -1.98% | -0.85% | -0.19% |
| Dividend Per Share | 1.68% | 1.69% | 1.69% | 1.70% | 1.71% |
| Payout Ratio | 0.23% | 0.19% | 0.12% | 0.12% | 0.06% |